Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients | BMJ: British Medical Journal | 2002 | 4.7K |
Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels | New England Journal of Medicine | 1998 | 4.5K |
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials | Lancet, The | 2010 | 3.8K |
Intensive versus moderate lipid lowering with statins after acute coronary syndromes | New England Journal of Medicine | 2004 | 3.8K |
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial | Lancet, The | 2005 | 3.2K |
Optimal medical therapy with or without PCI for stable coronary disease | New England Journal of Medicine | 2007 | 3.1K |
Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials | Lancet, The | 2003 | 3.1K |
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease | New England Journal of Medicine | 2009 | 2.8K |
Fractional flow reserve versus angiography for guiding percutaneous coronary intervention | New England Journal of Medicine | 2009 | 2.6K |
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study | Lancet, The | 2001 | 2.6K |
A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease | New England Journal of Medicine | 2004 | 2.3K |
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial | JAMA - Journal of the American Medical Association | 2002 | 2.3K |
Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease | Circulation | 2000 | 2.1K |
A prospective natural-history study of coronary atherosclerosis | New England Journal of Medicine | 2011 | 2K |
Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty | New England Journal of Medicine | 1979 | 2K |
Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge | Circulation | 1987 | 2K |
Intraaortic balloon support for myocardial infarction with cardiogenic shock | New England Journal of Medicine | 2012 | 1.9K |
Ischemia and reperfusion--from mechanism to translation | Nature Medicine | 2011 | 1.9K |
Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans | Circulation | 2002 | 1.7K |
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions | Journal of the American College of Cardiology | 2011 | 1.7K |
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines | Circulation | 2013 | 1.7K |
The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin | New England Journal of Medicine | 1998 | 1.7K |
Estrogen plus progestin and the risk of coronary heart disease | New England Journal of Medicine | 2003 | 1.6K |
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study | Lancet, The | 2007 | 1.6K |
Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses | New England Journal of Medicine | 1996 | 1.6K |